Venetoclax, Venetoclax, Acalabrutinib, Venetoclax
HO159
Phase 2 small_molecule active
Quick answer
Venetoclax, Venetoclax, Acalabrutinib, Venetoclax for Patients with relapsed CLL, Chronic lymphocytic leukemia is a Phase 2 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ology Bioservices Ireland LTD
- Indication
- Patients with relapsed CLL, Chronic lymphocytic leukemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active